Antimicrobial susceptibilities of Streptococcus pyogenes isolated from adult patients with respiratory tract and skin and soft tissue infections in four southern European countries [1]

Journal of Chemotherapy

Volumn 15, Issue 3, 2003, Pages 293-295

  Soriano, Francisco ^a   Granizo, J J ^a   Fernandez Roblas R ^a   Esteban, J ^a   Gadea, I ^a   Gracia, M ^a   Coronel, P ^b   Gimeno, M ^b   Rodenas E ^b  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^b Tedec Meiji Farma SA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFDITOREN; CEFOTAXIME; CEFPODOXIME; CEFUROXIME; CEPHEM DERIVATIVE; CLARITHROMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; PENICILLIN DERIVATIVE;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; EUROPE; HUMAN; IN VITRO STUDY; LETTER; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; RESPIRATORY TRACT INFECTION; SKIN INFECTION; SOFT TISSUE INFECTION; STREPTOCOCCUS PYOGENES; THROAT CULTURE;

EID: 0038684063     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2003.15.3.293     Document Type: Letter

References (10)

1. Guay, DR. Review of cefditoren, an advanced-generation, broad-spectrum oral cephalosporin. Clin Ther 2001; 23: 1924-37.
2. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing; eleventh informational supplement. M100-S11. NCCLS. Wayne, PA, 2001.
3. Bassetti M, Manno G, Collida A, et al. Erythromycin resistance in Streptococcus pyogenes in Italy. Emerg Infect Dis 2000; 6: 180-3.
4. Cocuzza C, Blandino G, Mattina R, Nicoletti F, Nicoletti G. Antibiotic susceptibility of group A streptococci in 2 Italian cities: Milano and Catania. Microb Drug Resist 1997; 3: 379-84.
5. Savoia D, Avanzini C, Bosio K, et al. Macrolide resistance in group A streptococci. J Antimicrob Chemother 2000; 45: 41-7.
6. Melo-Cristino J, Fernandes ML. Streptococcus pyogenes isolated in Portugal: macrolide resistance, phenotypes and correlation with T types. Portuguese surveillance group for the study of respiratory pathogens. Microb Drug Resist 1999; 5: 219-25.
7. Syrogiannopoulos GA, Grivea IN, Fitoussi F, et al. High prevalence of erythromycin resistance of Streptococcus pyogenes in Greek children. Pediatr Infect Dis J 2001; 20: 863-8.
8. Perez-Trallero E, Fernández-Mazarrasa C, García-Rey C, et al. Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob Agents Chemother 2001; 45: 3334-40.
9. Granizo JJ, Aguilar L, Casal J, Dal-Re R, Baquero F. Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). J Antimicrob Chemother 2000; 46: 959-64.
10. Giovanetti E, Prenna M, Repetto A, Biavasco F, Romagnoli M, Ripa S. Susceptibility of Streptococcus pyogenes from throat cultures to macrolide antibiotics and influence of collection criteria. Clin Microbiol Infect 1997; 3: 58-62.